BUZZ-U.S. STOCKS ON THE MOVE-Intercept, Red Hat, Qihoo, Centene
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were lower on Friday as a selloff in commodity markets showed no signs of easing. Dow Jones industrial average futures were down 0.48 percent at 17,272, S&P 500 futures were down 0.46 percent at 2,015.5 and Nasdaq 100 futures were down 0.17 percent at 4,561.75.
** INTERCEPT PHARMACEUTICALS INC, Thursday close $165.95, -8.10 pct premarket
The U.S. Food and Drug Administration has postponed by three months its decision on Intercept Pharmaceuticals' marketing application for its lead drug, to treat a kind of liver disease.
** RED HAT INC, Thursday close $78.86, +5.31 pct premarket
The Linux OS distributor raised its full-year revenue forecast for the second time, helped by a 14 percent jump in deferred revenue. The company reported better-than-expected Q3 profit, boosted by higher software subscription revenue.
** QIHOO 360 TECHNOLOGY CO, Thursday close $71.81, +2.07 pct premarket
The Chinese mobile security software maker said it agreed to be acquired by a consortium of investors for about $9.3 billion, including about $1.6 billion of debt.
** CENTENE CORP, Thursday close $61.86, +2.65 pct premarket
The drugmaker raised its 2015 profit forecast and reaffirmed its guidance for revenue, ahead of completing its $6.3 billion acquisition of smaller health insurer Health Net Inc. Continued...